Deficiency of α-dystroglycan in muscle-eye-brain disease

被引:93
作者
Kano, H
Kobayashi, K
Herrmann, R
Tachikawa, M
Manya, H
Nishino, I
Nonaka, I
Straub, V
Talim, B
Voit, T
Topaloglu, H
Endo, T
Yoshikawa, H
Toda, T
机构
[1] Osaka Univ, Grad Sch Med, Dept Post Genom & Dis, Div Funct Genom, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan
[3] Tokyo Metropolitan Inst Gerontol, Dept Glycobiol, Tokyo, Japan
[4] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan
[5] Univ Essen Gesamthsch, Dept Pediat & Pediat Neurol, Essen, Germany
[6] Hacettepe Childrens Hosp Med Ctr, Dept Pediat Neurol, Ankara, Turkey
[7] Hacettepe Childrens Hosp Med Ctr, Dept Pediat Pathol, Ankara, Turkey
关键词
muscle-eye-brain disease; muscular dystrophy; dystroglycan; glycosylation; POMGnT1; neuronal migration disorder;
D O I
10.1006/bbrc.2002.6608
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Dystroglycan is a component of the dystrophin-glycoprotein-complex, which is the major mechanism of attachment between the cytoskeleton and the extracellular matrix. Muscle-eye-brain disease (MEB) is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities and lissencephaly. We recently found that MEB is caused by mutations in the protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase (POMGnT1) gene. POMGnT1 is a glycosylation enzyme that participates in the synthesis of O-mannosyl glycan, a modification that is rare in mammals but is known to be a laminin-binding ligand of alpha-dystroglycan. Here we report a selective deficiency of alpha-dystroglycan in MEB patients. This finding suggests that alpha-dystroglycan is a potential target of POMGnT1 and that altered glycosylation of alpha-dystroglycan may play a critical role in the pathomechanism of MEB and some forms of muscular dystrophy. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:1283 / 1286
页数:4
相关论文
共 18 条
[1]   The fukutin protein family - predicted enzymes modifying cell-surface molecules [J].
Aravind, L ;
Koonin, EV .
CURRENT BIOLOGY, 1999, 9 (22) :R836-R837
[2]   Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan [J].
Brockington, M ;
Blake, DJ ;
Prandini, P ;
Brown, SC ;
Torelli, S ;
Benson, MA ;
Ponting, CP ;
Estournet, B ;
Romero, NB ;
Mercuri, E ;
Voit, T ;
Sewry, CA ;
Guicheney, P ;
Muntoni, F .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (06) :1198-1209
[3]   3 MUSCULAR-DYSTROPHIES - LOSS OF CYTOSKELETON EXTRACELLULAR-MATRIX LINKAGE [J].
CAMPBELL, KP .
CELL, 1995, 80 (05) :675-679
[4]  
Chiba A, 1997, J BIOL CHEM, V272, P2156
[5]   O-mannosyl glycans in mammals [J].
Endo, T .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :237-246
[6]   MEMBRANE ORGANIZATION OF THE DYSTROPHIN-GLYCOPROTEIN COMPLEX [J].
ERVASTI, JM ;
CAMPBELL, KP .
CELL, 1991, 66 (06) :1121-1131
[7]   DEFICIENCY OF A GLYCOPROTEIN COMPONENT OF THE DYSTROPHIN COMPLEX IN DYSTROPHIC MUSCLE [J].
ERVASTI, JM ;
OHLENDIECK, K ;
KAHL, SD ;
GAVER, MG ;
CAMPBELL, KP .
NATURE, 1990, 345 (6273) :315-319
[8]   Overview of N- and O-linked oligosaccharide structures found in various yeast species [J].
Gemmill, TR ;
Trimble, RB .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1426 (02) :227-237
[9]   Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse [J].
Grewal, PK ;
Holzfeind, PJ ;
Bittner, RE ;
Hewitt, JE .
NATURE GENETICS, 2001, 28 (02) :151-154
[10]   Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy [J].
Hayashi, YK ;
Ogawa, M ;
Tagawa, K ;
Noguchi, S ;
Ishihara, T ;
Nonaka, I ;
Arahata, K .
NEUROLOGY, 2001, 57 (01) :115-121